Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | KXIAY | JNJ |
|---|---|---|
| Price | $35.89 | $252.93 |
| Change today | ▼ 0.22% | ▼ 1.21% |
| Market cap | $574.79B | $609.54B |
| Return, 3 months | -28.0% | -4.9% |
| Return, year to date | +439.7% | +24.2% |
| Return, 1 year | – | +37.5% |
| P/E (TTM) | 53.6 | 29.3 |
| P/B | 1,937.9 | 7.2 |
| P/E percentile vs own 5y | – | 88th |
| Dividend yield | – | 2.07% |
| Revenue growth (YoY, latest qtr) | – | +6.6% |
| Net profit growth (YoY) | – | -0.1% |
| Gross margin | – | 67.9% |
| Operating margin | – | 26.8% |
| Net margin | – | 21.5% |
| Return on equity | – | 25.7% |
| Analyst target vs. price | – | +14.0% |
| Analyst buy share | – | 78% |
| RSI (14) | 52 | 30 |
| 30-day volatility | 75.6% | 17.1% |
| Max drawdown, 1 year | -66.6% | -11.0% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
